Verena Keller

Dr. Verena Keller

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
NLNicole Ludwig
Nicole Ludwig
TFTobias Fehlmann
Tobias Fehlmann
FKFabian Kern
Fabian Kern
MGManfred Gogol
Manfred Gogol
WMWalter Maetzler
Walter Maetzler
AKAndreas Keller
Andreas Keller
Blood-borne small non-coding (sncRNAs) are among the prominent candidates for blood-based diagnostic tests. Often, high-throughput approaches are applied to discover biomarker signatures. These have to be validated in larger cohorts and evaluated by adequate statistical learning approaches. Previously, we published high-throughput sequencing based microRNA (miRNA) signatures in Alzheimer’s disease (AD) patients in the United States (US) and Germany. Here, we determined abundance levels of 21 known circulating miRNAs in 465 individuals encompassing AD patients and controls by RT-qPCR. We computed models to assess the relation between miRNA expression and phenotypes, gender, age, or disease severity (Mini-Mental State Examination; MMSE). Of the 21 miRNAs, expression levels of 20 miRNAs were consistently de-regulated in the US and German cohorts. 18 miRNAs were significantly correlated with neurodegeneration (Benjamini-Hochberg adjusted P < 0.05) with highest significance for miR-532-5p (Benjamini-Hochberg adjusted P = 4.8 × 10−30). Machine learning models reached an area under the curve (AUC) value of 87.6% in differentiating AD patients from controls. Further, ten miRNAs were significantly correlated with MMSE, in particular miR-26a/26b-5p (adjusted P = 0.0002). Interestingly, the miRNAs with lower abundance in AD were enriched in monocytes and T-helper cells, while those up-regulated in AD were enriched in serum, exosomes, cytotoxic t-cells, and B-cells. Our study represents the next important step in translational research for a miRNA-based AD test.

16 April 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
JRJacqueline Rehner
Jacqueline Rehner
GSGeorges P. Schmartz
Georges P. Schmartz
TKTabea Kramer
Tabea Kramer
VKVerena Keller
Verena Keller
AKAndreas Keller
Andreas Keller
SBSoeren Becker
Soeren Becker
In 2019, researchers from the EAT-Lancet Commission developed the ‘Planetary Health (PH) diet’. Specifically, they provided recommendations pertaining to healthy diets derived from sustainable food systems. Thus far, it has not been analysed how such a diet affects the human intestinal microbiome, which is important for health and disease development. Here, we present longitudinal genome-wide metagenomic sequencing and mass spectrometry data on the gut microbiome of healthy volunteers adhering to the PH diet, as opposed to vegetarian or vegan (VV) and omnivorous (OV) diets. We obtained basic epidemiological information from 41 healthy volunteers and collected stool samples at inclusion and after 2, 4, and 12 weeks. Individuals opting to follow the PH diet received detailed instructions and recipes, whereas individuals in the control groups followed their habitual dietary pattern. Whole-genome DNA was extracted from stool specimens and subjected to shotgun metagenomic sequencing (~3 GB per patient). Conventional bacterial stool cultures were performed in parallel and bacterial species were identified with matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. We analysed samples from 16 PH, 16 OV, and 9 VV diet patterns. The α-diversity remained relatively stable for all dietary groups. In the PH group, we observed a constant increase from 3.79% at inclusion to 4.9% after 12 weeks in relative abundance of Bifidobacterium adolescentis. Differential PH abundance analysis highlighted a non-significant increase in possible probiotics such as Paraprevotella xylaniphila and Bacteroides clarus. The highest abundance of these bacteria was observed in the VV group. Dietary modifications are associated with rapid alterations to the human gut microbiome, and the PH diet led to a slight increase in probiotic-associated bacteria at ≥4 weeks. Additional research is required to confirm these findings.

29 March 2024 in One Health Outlook
Verified
Journal Article
Open access
PDF file
MRMichael E. G. Rosch
Michael E. G. Rosch
JRJacqueline Rehner
Jacqueline Rehner
GSGeorges P. Schmartz
Georges P. Schmartz
SMSascha K. Manier
Sascha K. Manier
UBUta Becker
Uta Becker
VKVerena Keller
Verena Keller
Background: Different production systems of livestock animals influence various factors, including the gut microbiota. Methods: We investigated whether changing the conditions from barns to free-range chicken farming impacts the microbiome over the course of three weeks. We compared the stool microbiota of chicken from industrial barns after introducing them either in community or separately to a free-range environment. Results: Over the six time points, 12 taxa—mostly lactobacilli—changed significantly. As expected, the former barn chicken cohort carries more resistances to common antibiotics. These, however, remained positive over the observed period. At the end of the study, we collected eggs and compared metabolomic profiles of the egg white and yolk to profiles of eggs from commercial suppliers. Here, we observed significant differences between commercial and fresh collected eggs as well as differences between the former barn chicken and free-range chicken. Conclusion: Our data indicate that the gut microbiota can undergo alterations over time in response to changes in production systems. These changes subsequently exert an influence on the metabolites found in the eggs. The preliminary results of our proof-of-concept study motivate larger scale observations with more individual chicken and longer observation periods.

11 November 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
JRJacqueline Rehner
Jacqueline Rehner
Madline P. GundMadline P. Gund
Madline P. Gund
SBSoeren Becker
Soeren Becker
MHMatthias Hannig
Matthias Hannig
SRStefan Rupf
Stefan Rupf
VKVerena Keller
Verena Keller
Background: The human microbiome holds promise for identifying biomarkers and therapeutic targets. In obesity, interactions between oral and gut communities are increasingly implicated and end in organ injury. Methods: From the IMAGINE study, we analyzed 418 shotgun metagenomes from three specimen types (dental plaque (n = 143; 65 non-obese, 78 obese), saliva (n = 166; 75 non-obese, 91 obese), and stool (n = 109; 57 non-obese, 52 obese)) to compare site-specific microbial shifts between obese (BMI > 30 kg/m2) and non-obese individuals. Differential abundance was assessed with ANCOM-BC; effect sizes were summarized as Cohen’s d. Results: Across all samples, we detected 240 bacterial species in plaque, 229 in saliva, and 231 in stool, with 46 species present across all three sites. Absolute effect sizes were significantly larger in plaque (mean |d| = 0.26) and saliva (0.25) than in stool (0.21; p = 9 × 10−3). Several taxa showed an opposite directionality between oral and gut sites, including Streptococcus salivarius and Bifidobacterium longum, indicating site-specific associations. Notably, Actinomyces sp. and Streptococcus sp. exhibited promising effect sizes as diagnostic markers. Conclusions: The oral and gut microbiomes capture complementary obesity-related signals, with stronger shifts observed in oral sites. We suggest that integrating oral and gut profiling could enhance diagnostic and therapeutic strategies in obesity.

17 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JRJacqueline Rehner
Jacqueline Rehner
MGMadline P. Gund
Madline P. Gund
SBSoeren L. Becker
Soeren L. Becker
MHMatthias Hannig
Matthias Hannig
SRStefan Rupf
Stefan Rupf
VKVerena Keller
Verena Keller
The human microbiome, distributed across various anatomical sites, holds promise for identifying diagnostic biomarkers and therapeutic targets in disease. In inflammatory bowel disease (IBD), including ulcerative colitis (UC), interactions between the gut and oral microbiomes are crucial for understanding disease mechanisms and guiding interventions. The IMAGINE study sequenced 1,931 specimens from saliva, plaque, stool, and other sources in patients and healthy controls. Here, we assess whether the oral (saliva/plaque) or gut microbiota provides greater diagnostic potential in IBD and examine shared dysregulation across sample types. Among 177 oral samples (102 healthy, 75 IBD) and 92 stool samples (57 healthy, 35 IBD), we identified 240 distinct strains in plaque, 229 in saliva, and 231 in stool, with 46 strains present in all three. Saliva showed a significantly higher average effect size (0.2) than stool (0.04) and plaque (0.06). Notably, Actinomyces sp., Bifidobacterium dentium , and Veillonella parvula exhibited increased effect sizes, suggesting their potential as diagnostic markers or therapeutic targets. These findings indicate that microbiome profiling in IBD may improve diagnostics and treatment strategies.

7 September 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
HSHannah Sabados
Hannah Sabados
SMSandra Möwius
Sandra Möwius
USUte Marie Stern
Ute Marie Stern
MMMaurice Michel
Maurice Michel
JSJörn M. Schattenberg
Jörn M. Schattenberg
VKVerena Keller
Verena Keller
Background: Obesity is frequently accompanied by metabolic dysfunction and micronutrient deficiencies, yet data on individuals with severe obesity (BMI ≥ 50 kg/m2) remain limited. Understanding how vitamin and mineral status changes across the adiposity continuum may optimize personalized nutritional management in severe obesity. Methods: We analyzed anthropometric, metabolic, hepatic, and micronutrient parameters in a retrospective, single-center cohort of adults evaluated before bariatric surgery, with a BMI range of 30 to 91 kg/m2 (mean 48.7 ± 8.7). Measurements included bioimpedance-derived body composition, liver elastography (CAP and stiffness), and fasting laboratory parameters, vitamins B1, B6, B12, D, and folate and minerals (iron, selenium, and magnesium). Correlation analysis, principal component analysis (PCA), and random forest (RF) classification were applied to identify the variables most strongly associated with BMI and metabolic phenotypes. Results: Several micronutrient concentrations, most notably vitamin D, folate and vitamin B6, declined progressively with increasing BMI. Vitamin D additionally correlated inversely with HbA1c. PCA revealed a separation of participants with extreme obesity driven by anthropometric and hepatic parameters, while micronutrients clustered inversely. RF classification identified HbA1c, hepatic enzymes (ALAT and γ-GT) and body-composition measures (waist circumference and visceral fat) as the strongest discriminators of T2DM, MASLD and high BMI, respectively. Combined MASLD and T2DM was associated with the most pronounced vitamin B6 depletion, whereas vitamin D was low across metabolic subgroups. Conclusions: Severe obesity is associated with distinct micronutrient depletion patterns that mirror metabolic deterioration. Integrating nutritional and metabolic profiling enables refined risk stratification and may, pending prospective validation, inform targeted supplementation strategies in individuals with severe obesity.